Skip to main content

Table 2 Participant Demographics

From: Implementation-effectiveness trial of systematic family health history based risk assessment and impact on clinical disease prevention and surveillance activities

Demographic

Total population

Familial Risk recommendationa

N (%)

Monogenic recommendationa

N (%)

Any increased risk recommendationa

N (%)

N

1829

278 (15.2)

543 (29.7)

762 (41.7)

Age (SD)

56.2 (13.9)

51.6 (11.4)b

55.3 (13.6)

54.6 (13.1) b

Female

1273 (69.6)

233 (83.8) b

424 (78.1) b

558 (79.4) b

Race

 • Asian

20 (1.1)

3 (1.1)

5 (0.9)

6 (0.9)

 • Black

139 (7.9)

20 (7.5)

46 (8.7)

56 (8.2)

 • White

1561 (88.7)

238 (89.5)

465 (87.7)

602 (88.5)

 • Other

39 (2.2)

5 (1.9)

14 (2.6)

16 (2.4)

Hispanic Ethnicity

33 (2.3)

3 (1.4)

12 (2.8)

13 (2.4)

Insurance

 • Private

1250 (69.1)

227 (83.2) b

380 (70.4)

511 (73.3) b

 • Medicare

513 (28.4)

38 (13.9) b

138 (25.6)

161 (23.1) b

 • Medicaid

31 (1.7)

3 (1.1)

12 (2.2)

13 (1.9)

 • Other

14 (0.8)

5 (1.8) b

10 (1.9) b

12 (1.7) b

College education or more

1394 (76.2)

192 (69.1) b

408 (75.1)

518 (73.7) b

  1. aRisk recommendations for outcomes reported in this manuscript (i.e. familial recommendation = breast MRI, chemoprevention, earlier CRC screening, EMF CRC screening; monogenic recommendation = genetic counselling.)
  2. bp-value < 0.05 for comparison of given category to total population